SPH's plummeting advertising earnings won't slow down soon, say analysts

Its AR declined by 8.6% last quarter.

The media firm’s declining print readership isn’t helping its advertising revenue, and analysts say the downward trend is here to stay.

According to a report by UOB Kay Hian, even in the event that the economy bounces back the decline in print readership will likely more than offset any incremental adspend.

“Display and Recruitment ads down 6.0% and 14.6% respectively. Underscoring the weakness in total ad page counts was the sharp 14.6% decline in Recruitment ads, and a 6.0% decline in Display ads,” the report noted.

Meanwhile, the media business nevertheless continues to be SPH’s primary cashflow generator.

“Its diversification into other businesses, such as property, has yet to supplant the media business. As such, operating cashflow will likely trend the decline in its media business. SPH is unlikely to pay beyond its ability to generate cash, and dividends might be at risk,” the report added.
 

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

DBS and OCBC expected to deliver steady Q1 net profits
Their net interest margins will ease as a result of their Hong Kong loans.
Singapore's maritime cluster navigates towards digital, green future
Adapting to emerging challenges, such as the adoption of alternative fuels, is deemed crucial for the country's maritime sector.
SCG and A*STAR unveil joint labs for cellular immunotherapy enhancement
The partnership has a funding of nearly $30m supported under Singapore's Research, Innovation and Enterprise 2025 plan.
Healthcare